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Na+Shortened action-potential duration (APD) and blunted APD rate adaptation are hallmarks of chronic atrial
ﬁbrillation (cAF). Basal and muscarinic (M)-receptor-activated inward-rectiﬁer K+ currents (IK1 and IK,ACh,
respectively) contribute to regulation of human atrial APD and are subject to cAF-dependent remodeling.
Intracellular Na+ ([Na+]i) enhances IK,ACh in experimental models but the effect of [Na+]i-dependent regulation
of inward-rectiﬁer K+ currents onAPD in human atrialmyocytes is currently unknown. Here,we report a [Na+]i-
dependent inhibition of outward IK1 in atrial myocytes from sinus rhythm (SR) or cAF patients. In contrast, IK,ACh
activated by carbachol, a non-selective M-receptor agonist, increased with elevation of [Na+]i in SR. This [Na+]i-
dependent IK,ACh regulation was absent in cAF. Including [Na+]i dependence of IK1 and IK,ACh in a recent compu-
tational model of the human atrialmyocyte revealed that [Na+]i accumulation at fast rates inhibits IK1 and blunts
physiological APD rate dependence in both groups. [Na+]i-dependent IK,ACh augmentation at fast rates increased
APD rate dependence in SR, but not in cAF. These results identify impaired Na+-sensitivity of IK,ACh as one poten-
tial mechanism contributing to the blunted APD rate dependence in patients with cAF. This article is part of a
Special Issue entitled “Na+ Regulation in Cardiac Myocytes”.
© 2013 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
Atrial ﬁbrillation (AF) is the most common sustained cardiac arrhyth-
mia and is associated with increased morbidity and mortality [1]. Short-
ening of action-potential duration (APD) is a well-established marker of
AF-associated electrical remodeling and contributes to the maintenance
of the arrhythmia [2]. Reduced depolarizing L-type Ca2+ current (ICa,L)
and increased repolarizing inward-rectiﬁer K+ currents are major con-
tributors to APD shortening in AF [3–5]. In addition, physiological APD
rate adaptation, resulting in shorter APD at fast pacing rates and longer
APD at slow pacing rates, is impaired in AF [5]. Previous studies haveential; APD, AP duration; cAF,
sal inward-rectiﬁer K+ current;
a+-K+ ATPase current; [Na+]i,
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blished by Elsevier Ltd. All rights reindicated that reduced ICa,L, remodeling of intracellular Ca2+ handling,
and K+-current alterations contribute to the loss of rate-dependent APD
adaptation in AF [6–9]. Using computational modeling, we have recently
discovered an important role for increased Na+–K+ ATPase current
(INaK),which increases at fast rates due to intracellularNa+ ([Na+]i) accu-
mulation, thereby contributing to rate dependent APD adaptation in
human atrial myocytes [10]. However, Na+-dependent regulation of
other currentsmay also inﬂuence APD and its rate-dependent adaptation.
In atrial myocytes, basal and muscarinic (M)-receptor-activated
inward-rectiﬁer K+ currents IK1 and IK,ACh play key roles in the mainte-
nance of the resting membrane potential and contribute to APD regula-
tion.We and others have shown that chronic AF (cAF) is associatedwith
increased IK1 but lower agonist-dependent IK,ACh [11,12]. Whereas IK1 is
active under basal conditions, IK,ACh channels are responsible for the ef-
fects of acetylcholine, adenosine and sphingosine-1 phosphate in the
human atrium and are activated through stimulation of appropriate
G-protein-coupled receptors and subsequent binding of Gβγ-subunits
to the channel [13–15]. AlthoughG-protein-dependent activation is typ-
ical for IK,ACh only, IK1 and IK,ACh share common regulatory mechanisms
mediated by other factors such as intracellular Mg2+ and polyamines,
extracellular K+, the anionic phospholipid phosphatidylinositol-4,5-
bisphosphate (PIP2) and channel phosphorylation [13]. Importantly,served.
Table 1
Characteristics of patients.
SR cAF
Patients, n 16 11
Gender, M/F 10/6 8/3
Age, y 73.3 ± 1.9 72.0 ± 2.3
Body mass index, kg/m2 30.3 ± 1.3 27.8 ± 1.3
CAD, n 10 2a
MVD/AVD, n 4 8a
CAD + MVD/AVD, n 2 1
Hypertension, n 15 9
Diabetes, n 9 3
Hyperlipidemia, n 11 7
LVEF, % 57.1 ± 3.2 51.5 ± 4.5
LAD, mm 42.2 ± 1.3 48.7 ± 3.3
LVEDD, mm 53.6 ± 1.6 50.4 ± 1.7
IVS, mm 14.0 ± 0.6 13.4 ± 0.6
LVPW, mm 13.5 ± 0.5 12.7 ± 0.7
Digitalis, n 1 4
ACE inhibitors, n 8 6
AT1 blockers, n 3 0
β-Blockers, n 14 11
Dihydropyridines, n 5 3
Diuretics, n 10 9
Nitrates, n 9 1a
Lipid-lowering drugs, n 10 5
CAD, coronary artery disease; MVD/AVD,mitral/aortic valve disease; LVEF, left ventricular
ejection fraction; LVEDD, left ventricular end-diastolic diameter; LAD, left atrial diameter;
IVS, interventricular septum thickness; LVPW, left ventricular posterior wall thickness;
ACE, angiotensin-converting enzyme; AT, angiotensin receptor.
a P b 0.05 vs. SR from Fisher's exact test for categorical variables.
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at least two distinct mechanisms: (i) direct interaction of [Na+]i with
negatively charged amino acids at the C-terminus of the IK,ACh channel
subunit Kir3.4 [16–18] and (ii) [Na+]i-dependent augmentation of
dissociation and re-arrangement of G-protein subunits [19,20].
The [Na+]i-dependent regulation of IK,ACh has been studied in
heterologous expression systems and in experimental preparations of
rat atrial myocytes [16–19], but it is unknown whether (i) similar
[Na+]i-dependent regulation occurs in human atrial myocytes,
(ii) basal inward-rectiﬁer K+ current also varies with changes in
[Na+]i, (iii) regulation of inward-rectiﬁer K+ currents by [Na+]i has
an impact on human atrial APD and/or its rate dependence, and
(iv) [Na+]i-dependent modulation of inward-rectiﬁer K+ currents
is altered in human AF. In the present study we hypothesized that re-
duced expression of the [Na+]i-sensitive Kir3.4 subunit, which contrib-
utes to the lower CCh-activated IK,ACh in cAF [11,12], removes the
physiological [Na+]i dependence of IK,ACh, resulting in blunted APD
rate adaptation after M-receptor activation. We employed a combined
experimental and computational approach to investigate the role of
[Na+]i in APD rate adaptation via its effects on inward-rectiﬁer K+ cur-
rents in atrial myocytes from patients in sinus rhythm (SR) and cAF.
2. Materials & methods
The investigationwas approved by the ethics committees of Dresden
University of Technology (No: EK790799) and Medical Faculty Mann-
heim, University of Heidelberg (#2011-216N-MA). The study conforms
with the principles outlined in the Declaration of Helsinki (Cardiovascu-
lar Research1997; 35:2–4). Each patient gavewritten informed consent.
2.1. Immunoblots
Primary antibodies against Kir3.1 (1:1000; Alomone Labs, Jerusalem,
Israel) and Kir3.4 (1:200, Santa Cruz Biotechnology, Santa Cruz, USA)
were used to quantify corresponding proteins in atrial homogenates
by immunoblotting as described [21]. Peroxidase-conjugated goat
anti-rabbit (1:2500 for Kir3.1; Sigma-Aldrich, St. Louis, USA) anddonkey
anti-goat antibodies (1:5000 for Kir3.4; Santa-Cruz Biotechnology, Santa
Cruz, USA) were used as secondary antibodies and visualized by
chemiﬂuorescence (GE Healthcare, Chalfont St Giles, UK). Quantity-
One software (Bio-Rad Laboratories, Hercules, USA) was used for quan-
tiﬁcation. Stripping buffer (Carl Roth GmbH, Karlsruhe, Germany) was
used to remove primary Kir3.1 antibodies to allow determination of
Kir3.4 expression in the same gel. Calsequestrin expression (1:2500
anti-CSQ, Dianova, Hamburg, Germany; and 1:30,000 goat anti-rabbit)
was quantiﬁed as loading control.
2.2. Human atrial myocyte isolation
Right-atrial samples were dissected from atrial appendages in 16 SR
patients and 11 patients with cAF (>6 months, Table 1). Atrial
myocytes were isolated using a standard protocol [22], suspended in
storage solution (mmol/L: KCl 20, KH2PO4 10, glucose 10, K-glutamate
70, β-hydroxybutyrate 10, taurine 10, EGTA 10, albumin 1, pH = 7.4)
and investigated within 6 h. Only well-striated, rod-shaped myocytes
were used for current-recordings. Cell capacitance averaged 76.0 ±
3.3 pF (n = 36/16) and 115.3 ± 6.8 pF (n = 32/11) in SR and cAF
patients, respectively (P b 0.001). Therefore, current amplitudes were
corrected for cell size and expressed as current densities in pA/pF.
2.3. Solution and chemicals
Throughout the electrophysiological experiments myocytes were
superfused with a bath solution containing (mmol/L): NaCl 120, KCl
20, MgCl2 1, CaCl2 2, glucose 10, HEPES 10, pH = 7.4 at 22–24 °C.Drugs were applied via a rapid-solution exchange system (ALA Scien-
tiﬁc Instruments, Farmingdale, USA).
The standard pipette solution contained (in mmol/L): K-aspartate
80, NaCl 8, KCl 40, Mg-ATP 5, EGTA 2, GTP-Tris 0.1, HEPES 10, and
pH = 7.4. Total Na+ concentration of this solution ([Na+]i) was
8 mmol/L. As in previous studies [17], standard pipette solutions
containing different Na+ concentrations (0 mmol/L and 60 mmol/L)
were made up by corresponding changes in [KCl] and [K-aspartate].
The calculated K+ reversal potentials were −53 mV, −51 mV and
−45 mV for the 0 mmol/L [Na+], 8 mmol/L [Na+] and 60 mmol/L
[Na+] pipette solution, respectively.
All drugs were from Sigma-Aldrich (St. Louis, USA).
2.4. Electrophysiological recordings
Currents were measured at room temperature using the voltage-
clamp technique. ISO-2 software (MFK, Niedernhausen, Germany) was
used for data acquisition and analysis, as previously described [23,24].
Borosilicate glass microelectrodes had tip resistances of 2–5 MΩ when
ﬁlled with pipette solution. Seal-resistances were 4–8 GΩ. Series resis-
tance and cell capacitance were compensated. Data were not corrected
for the liquid junction potential (−12 mV, JPCalc software).
2.5. Computational modeling
A recently published computational model of the human atrial AP
[10] was extended to investigate the effect of Na+-dependent regula-
tion of IK1 and IK,ACh on APD rate dependence. The model formulations
of IK1 and IK,ACh were updated to match the experimental data on
basal current and CCh-activated current, respectively (Fig. S2 in the
supporting information). A square-root dependence of whole-cell con-
ductance on extracellular K+ ([K+]o) [25,26] was employed to adjust
both currents for the difference in [K+]o (20 mmol/L in experimental
recordings, 5.4 mmol/L in AP simulations). An overview of the adjusted
formulations and model validation is presented in the Supplemental
Information.
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Differences between group means for continuous data were com-
pared by unpaired Student's t-test or by one-way ANOVA and
Bonferroni–Holm post-hoc test. Frequency data were analyzed with
χ2 statistics. Data are mean ± SEM. P b 0.05 was considered statisti-
cally signiﬁcant. N-numbers (n = X/Y) represent number of cells/
number of patients.3. Results
3.1. Stoichiometry of Kir3.1 and Kir3.4 subunit expression in SR and cAF
The cardiac IK,ACh channel is composed of Kir3.1 and Kir3.4 subunits
[13]. Previous work has shown that [Na+]i sensitivity of IK,ACh is exclu-
sively mediated by Kir3.4 subunits [17,18] and that Kir3.4 expression
is reduced in cAF [11,12]. We investigated protein expression of Kir3.1
and Kir3.4 on the same Western-blot membranes in homogenates of
right-atrial appendages from patients with SR or cAF. Consistent with
previous results [12], we found that cAF was associated with lower
protein levels of Kir3.1 (−45.8 ± 8.2%, Fig. 1A, left panel) and Kir3.4
(−64.3 ± 5.4%; Fig. 1A, right panel). Since Kir3.4 subunit expression
was quantiﬁed on the same Western-blot membranes used for Kir3.1
determination after removal of Kir3.1 antibodies with stripping buffer,
a direct relation of the relative expression of Kir3.4 to Kir3.1 could be
obtained. We found that the cAF-associated reduction in Kir3.4 expres-
sion was stronger compared to Kir3.1 and that the calculated Kir3.4/
Kir3.1 ratio was signiﬁcantly reduced in cAF (cAF: 0.36 ± 0.05, n = 7Kir3.1
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Fig. 1. Expression of IK,ACh-channel subunits in SR and cAF. A. Representative Western blot of
(Mean ± SEM) of protein levels in cAF normalized to SR. ***P b 0.001 versus SR. B. Ratio of Ki
samples.vs. SR: 0.53 ± 0.05, n = 9; P b 0.05; Fig. 1B). These results suggest
that [Na+]i-dependent regulation of IK,ACh may be impaired in cAF due
to an altered Kir3.4/Kir3.1 stoichiometry.3.2. [Na+]i dependence of basal inward-rectiﬁer K
+ current in SR and
cAF
To determine the functional effects of [Na+]i on inward-rectiﬁer K+
currents, whole-cell voltage-clamp experiments were performed in
myocytes isolated from right-atrial appendages (Fig. 2A). Agonist-
independent basal current was measured using 500 ms voltage ramps
between −120 mV and +60 mV applied at 0.1 s−1 from a holding
potential of −90 mV, i.e., negative to the K+ reversal potential,
resulting in inward K+ currents (Fig. 2B). Typical time courses of cur-
rent amplitudes measured in atrial myocytes from SR and cAF patients
are shown in Fig. 2C. Agonist-activated IK,ACh wasmeasured in the pres-
ence of CCh (2 μmol/L). The nature of basal current and IK,ACh as inward
rectiﬁers was conﬁrmed in eachmyocyte by applying Ba2+ (1 mmol/L)
and obtaining Ba2+-sensitive currents after subtraction of leak current.
Fig. 2D shows representative current–voltage relations of basal cur-
rent (a–c) and agonist-dependent IK,ACh (b–a) in SR and cAF with
8 mmol/L [Na+]i. In accordance with previous data [3,11,12,23,27–29],
basal current at −100 mV was larger in cAF compared to SR. On
average, basal current was −19.51 ± 2.01 pA/pF, n = 15/8 in cAF vs.
−11.93 ± 1.67 pA/pF n = 15/7, in SR (P b 0.01; Figs. 3A,B) at
−100 mV and 8 mmol/L [Na+]i. Mintert et al. have previously shown
that inward basal current in rat atrial myocytes is independent of
[Na+]i [17]. Consistent with these results we found that loweringcAF
7
*
 ratio
53 kDa
47 kDa
Kir3.4
0
25
50
75
100
125
SR cAF
K
ir3
.
4 
n
o
rm
.
 
to
 
CS
Q
(%
 
o
f S
R
)
Kir3.4
CSQ
SR cAF
***
79
Kir3.1 (left) and Kir3.4 (right) together with corresponding densitometric quantiﬁcation
r3.4/Kir3.1 protein levels (Mean ± SEM), *P b 0.05 vs. SR. Numbers in bars indicate atrial
-90 mV
-120 mV
+60 mV
-120 mV
+60 mV
10 s
[K+]o=20 mmol/L, room temperature
Basal
current
Carbachol
2 µmol/L
Ba2+
1 mmol/L
Basal
current
Carbachol
2 µmol/L
Ba2+
1 mmol/L
10 pA/pF
10 s
cAFSR
b
a c
a
b
c
[Na+]i = 8 mmol/L
-120 -100 -80 -60 -40 -20 20 40 60
-30
-20
-10
VM (mV)
I M
 
(p
A/
pF
)
I M
 
(p
A/
pF
)a-c
b-c
-120 -100 -80 -60 -40 -20 20 40 60
-30
-20
-10
VM (mV)
a-c
b-c
Basal
current
IK,ACh
Basal
current
IK,ACh
10 µm
A
C
D
B
Fig. 2. Electrophysiological recordings of inward-rectiﬁer currents in atrial myocytes from patients with SR and cAF. A. Representative human right atrial myocyte. B. Voltage-clamp
protocol. Holding potential was−90 mV with depolarizing ramp pulses from−120 mV to +60 mV. C. Representative time-course of inward-rectiﬁer current in SR (left) and cAF
(right) at [Na+]i = 8 mmol/L. Basal current was deﬁned as Ba2+ (1 mmol/L)-sensitive current and IK,ACh was deﬁned as carbachol (CCh, 2 μmol/L)-dependent current increase.
D. Corresponding current–voltage curves of basal current (a–c) and CCh-activated IK,ACh (b–a).
145N. Voigt et al. / Journal of Molecular and Cellular Cardiology 61 (2013) 142–152[Na+]i to 0 mmol/L had no effect on inward basal current in either SR
(−10.51 ± 1.86 pA/pF, n = 12/7) or cAF myocytes (-17.93 ±
3.06 pA/pF, n = 8/3). When [Na+]i was increased to 60 mmol/L a
slight but non-signiﬁcant decrease in inward basal current was
observed in SR (−8.35 ± 1.86 pA/pF, n = 10/4) and cAF (−16.23 ±
2.55 pA/pF, n = 9/3; Figs. 3A,B).
Single-channel recordings of IK1 in guinea-pig atrial myocytes
have indicated that [Na+]i selectively decreases the unitary ampli-
tude of the outward-current component [30]. In accordance, we
found a signiﬁcant reduction in whole-cell outward basal current at
−10 mV with increasing [Na+]i (Figs. 3A,B). Outward basal current
was 0.18 ± 0.04 pA/pF, n = 15/7 and 0.30 ± 0.09 pA/pF, n = 15/8
at physiological [Na+]i in SR and cAF, respectively. Lowering [Na+]i
to 0 mmol/L increased basal current to 0.39 ± 0.12 pA/pF, n = 12/7
and 0.48 ± 0.16 pA/pF, n = 8/3, whereas increased [Na+]i of
60 mmol/L decreased basal current to 0.06 ± 0.09 pA/pF, n = 11/4 and
0.08 ± 0.07 pA/pF, n = 9/3, respectively. The stronger reduction of out-
ward compared to inward basal current suggests a [Na+]i-dependent
increase in rectiﬁcation of basal current. In agreement, ratios of basal cur-
rent at−10 and−100 mVwere signiﬁcantly reduced inmagnitude from-0.05 ± 0.01 to −0.03 ± 0.01 and −0.00 ± 0.01 in SR with 0, 8 and
60 mmol/L [Na+]i, respectively (Fig. S1A, left panel of the supporting
information). Similarly, current ratios were−0.04 ± 0.01,−0.02 ± 0.0
and −0.01 ± 0.01 with 0, 8 and 60 mmol/L [Na+]i in cAF (Fig. S1A,
right panel). Taken together, our data suggest that the outward-current
component of basal inward-rectiﬁer current in human atrial myocytes is
regulated by [Na+]i with lower outward currents at higher [Na+]i.
3.3. [Na+]i dependence of CCh-activated IK,ACh in SR and cAF
Application of CCh (2 μmol/L, 2 min) resulted in a rapid, reversible
current increase (Figs. 2C,D), which was deﬁned as agonist-dependent
IK,ACh. The CCh-dependent current increase was larger in SR compared
to cAF at any [Na+]i (Fig. 4A), conﬁrming previous results with physio-
logical [Na+]i [11,12,23,27,29].
It is well known that agonist-activated IK,ACh increaseswith elevation
of [Na+]i in experimental models and expression systems [16–20]. In
accordance, we found that CCh-activated IK,ACh at −100 mV increased
from −4.34 ± 0.75 pA/pF (n = 12/7) at 0 mmol/L [Na+]i to
−6.55 ± 0.75 pA/pF (n = 13/7) at 8 mmol/L [Na+]i in SR myocytes.
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Fig. 3. [Na+]i dependence of basal inward-rectiﬁer current in SR and cAF. A. Representative basal current–voltage relationships with 0, 8 and 60 mmol/L [Na+]i in SR (left) and cAF
(right). Top panel shows outward-current component (boxed region in lower panel) at an expanded scale. B. Basal current at−10 mV (top) and−100 mV (bottom) with 0, 8 and
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146 N. Voigt et al. / Journal of Molecular and Cellular Cardiology 61 (2013) 142–152Elevation of [Na+]i to 60 mmol/L further increased IK,ACh to−10.61 ±
1.65 pA/pF (n = 10/4; Figs. 4A,B, left panels). In contrast, IK,ACh was
−1.71 ± 0.41 pA/pF (n = 7/3) at 0 mmol/L [Na+]i in cAF and did
not signiﬁcantly increase at higher [Na+]i (−2.47 ± 0.41 pA/pF, n =
15/8 and −1.64 ± 0.75 pA/pF, n = 9/3 at 8 mmol/L and 60 mmol/L,
respectively; Figs. 4A,B, right panels), suggesting an impaired [Na+]i-
dependent regulation of IK,ACh in cAF. Similar results were obtained for
the outward-current component at −10 mV (Fig. 4B, top panels). In
SR, the relative outward-current component (ratio of current level at
−10 mV and−100 mV) of IK,ACh was -0.15 ± 0.03 (n = 12/7) in the
presence of 8 mmol/L [Na+]i and did not change when [Na+]i was
lowered to 0 mmol/L (−0.14 ± 0.02, n = 13/7) or increased to
60 mmol/L (−0.12 ± 0.01, n = 10/4; Fig. S1B of the supporting infor-
mation, left panel), pointing to comparable [Na+]i-dependent changes
of both the inward and outward components of IK,ACh. Similarly, relative
outward-current components of CCh-activated IK,ACh were unchanged
in cAF and were comparable to SR (Fig. S1B, right panel). Ratios ofcurrent levels at −10 mV and −100 mV were larger compared to
basal-current ratios (Fig. S1), indicating weaker inward rectiﬁcation
of CCh-stimulated IK,ACh compared to basal current. Overall, in cAF
CCh-activated IK,ACh is lower and its [Na+]i-dependent stimulation is
impaired, in agreement with our hypothesis.3.4. Role of [Na+]i-dependent regulation of basal and CCh-activated
inward-rectiﬁer currents in APD rate adaptation
To investigate the effect of the [Na+]i-dependent regulation of basal
and CCh-activated inward-rectiﬁer K+ currents on atrial repolarization
in SR and cAF,we extended a recent computationalmodel of the human
atrial myocyte [10] to incorporate Na+ dependence of IK1 and IK,ACh
(Fig. S2 of the supporting information). APD rate dependence in the
SR model with adjusted inward-rectiﬁer formulations in the absence
of CCh was consistent with experimental recordings (Fig. S3).
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tion from 8.4 mmol/L at a pacing rate of 0.5 Hz to 12.1 mmol/L and
10.8 mmol/L at 3.3 Hz in SR and cAF, respectively (Fig. 5A; horizontal
dashed lines). Previously, we have shown that the increase in [Na+]i
contributes to the reduction in APD at fast rates due to increased
repolarizing INaK and that the reduced [Na+]i accumulation in cAF,
resulting from the smaller Ca2+-transient amplitude and subsequent
reduction in Ca2+ extrusion/Na+ loading via the Na+–Ca2+ exchanger,
contributes to a blunted APD rate dependence [10]. To investigate
whether rate-dependent alterations in [Na+]i can also affect APD rateadaptation via modulation of inward-rectiﬁer K+ currents, model out-
put with dynamic (physiological) [Na+]i dependence of IK1 and IK,ACh
was compared to that when the [Na+]i sensed by IK1 and IK,ACh was
ﬁxed at 8.4 mmol/L (Fig. 5A, dashed-dotted lines). Increased [Na+]i at
fast pacing rates inhibited outward IK1 (Fig. 5B, solid lines), resulting
in a 5% longer APD at 3.3 Hz pacing in both SR and cAF (Fig. 5C, solid
lines) compared to simulations without [Na+]i-dependent regula-
tion of IK1 (dashed lines). These data indicate that [Na+]i-dependent
regulation of IK1 blunts APD rate dependence in both groups (Fig. 5C,
arrows).
Without [Na+]i dependence of IK1
With [Na+]i dependence of IK1
A
B
C
Fig. 5. Effects of [Na+]i-dependent regulation of IK1 on APD rate dependence in the absence of CCh. A. Rate dependence of [Na+]i in SR (left) or cAF (right). Horizontal dashed lines
indicate maximum [Na+]i at 3.3 Hz pacing rate. Horizontal dashed-dotted line represents the [Na+]i at 0.5 Hz pacing (8.4 mmol/L) which was used to ﬁx the rate dependence of
[Na+]i-dependent regulation. B. Rate dependence of IK1 (grey area) using ﬁxed [Na+]i dependence of IK1 (dashed lines) or dynamic (physiological) [Na+]i-dependent regulation
(solid lines). C. APD rate dependence in the presence of ﬁxed [Na+]i dependence of IK1 (dashed lines) or dynamic (physiological) [Na+]i-dependent regulation (solid lines). Arrows
indicate the effect of [Na+]i-dependent regulation of IK1 on APD rate dependence.
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pacing frequencies and this response was blunted in cAF (Fig. S4), con-
sistent with the effect of CCh in whole-cell current-clamp experiments
in human atrial myocytes [11].
Similar to the absence of CCh, [Na+]i increased with increasing pac-
ing rate in the presence of CCh (Fig. 6A), resulting in reduced IK1 (Fig. 6B,
light grey area). However, in SR, but not in cAF, [Na+]i-dependent stim-
ulation of IK,ACh was able to offset the reduced IK1 at fast rates (Fig. 6B,
dark grey area). As a consequence, the increased total inward-rectiﬁer
current decreased APD (Fig. 6C, left panel, solid line) below the value
observed in the absence of [Na+]i-dependent regulation (Fig. 6C, left
panel, dashed line). This stronger APD reduction at fast rates resulted
in a more pronounced APD rate dependence. In contrast, [Na+]i-depen-
dent effects on IK,ACh are absent in cAF (Fig. 4). As such, APD in the pres-
ence of Na+-regulation of IK1/IK,ACh (Fig. 6C, right panel, solid line)
remains longer than in its absence (Fig. 6C, right panel, dashed line) be-
cause of the inhibitory effect of [Na+]i on repolarizing outward IK1
(Fig. 6C, right panel), in the face of a small [Na+]i-independent outward
IK,ACh.4. Discussion
We evaluated the effect of [Na+]i variation on inward-rectiﬁer K+
currents in atrial myocytes from patients with SR and cAF to determine
the inﬂuences of [Na+]i-dependent processes on APD rate adaptation(Fig. 7). We found a decrease in outward-current component of basal
IK1 with higher [Na+]i in both SR and cAF. In SR, the CCh-activated
IK,ACh increased with elevation of [Na+]i without changes in rectiﬁca-
tion, whereas in cAF, the [Na+]i-dependent increase of CCh-activated
IK,ACh was impaired. The [Na+]i-dependent inhibition of IK1 blunted
APD rate dependence in the absence of cholinergic stimulation in both
SR and cAF. Simulated [Na+]i-dependent IK,ACh regulation increased
APD rate dependence in SR but reduced it in cAF. Collectively, our data
point to the possibility that the loss of [Na+]i dependence of IK,ACh in
cAF, likely resulting from a reduced Kir3.4:Kir3.1 stoichiometry, may
have important consequences for the in vivo rate-dependent APD
adaptation in cAF patients.4.1. Comparison with previous studies
Reduced effective refractory period, largely determined by reduced
atrial APD, is a hallmark feature of AF and facilitates AF-maintaining
reentrant circuits [2,5]. In addition, APD rate adaptation is impaired in
cAF [2,31] and a lack of rate adaptation of the atrial effective refractory
period has been correlated with an increased vulnerability to atrial
tachyarrhythmias [32].
Sustained AF leads to remodeling of various ionic currents [2]. Re-
duced ICa,L has traditionally been proposed as the major mechanism
underlying reduced APD rate adaptation in AF. However, Kneller et al.
have shown that ion-channel remodeling alone is insufﬁcient to explain
Without [Na+]i dependence of IK1 & IK,ACh
With [Na+]i dependence of IK1 & IK,ACh
A
B
C
Fig. 6. Effects of [Na+]i-dependent regulation of IK1 on APD rate dependence in the presence of CCh. A. Rate dependence of [Na+]i in SR (left) or cAF (right). Horizontal dashed lines
indicate maximum [Na+]i at 3.3 Hz pacing rate. Horizontal dashed-dotted line represents the [Na+]i at 0.5 Hz pacing (8.4 mmol/L) which was used to ﬁx the rate dependence of
[Na+]i-dependent regulation. B. Rate dependence of IK1 (light grey area) and IK,ACh (dark grey areas) using ﬁxed [Na+]i-dependent regulation (dashed lines) or dynamic (physiological)
[Na+]i-dependent regulation (solid lines). C. APD rate dependence in the presence of ﬁxed [Na+]i dependence of IK1 and IK,ACh (dashed lines) or dynamic (physiological) [Na+]i-dependent
regulation (solid lines) in the presence of CCh. Arrows indicate the effect of combined [Na+]i-dependent regulation of IK1 and IK,ACh on APD rate dependence.
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that the combined remodeling of ion-channel function and intracellular
Ca2+ handling was responsible for this phenomenon. In a recent
modeling study, we identiﬁed an important role for [Na+]i accumula-
tion and subsequent increases in INaK at fast rates in APD adaptation in
human atrial myocytes [10]. A close interplay between Na+- and
Ca2+-dependent processes in APD rate adaptation is to be expected
given the joint regulation of both ions, e.g., via the Na+–Ca2+-
exchanger.
Inward-rectiﬁer K+ currents are also altered by AF-dependent re-
modeling. Up-regulation of basal inward-rectiﬁer IK1, down-regulation
of acetylcholine-activated IK,ACh and development of an inwardly-
rectifying K+ current that has the properties of IK,ACh but is active
in the absence of M-receptor agonists (constitutively-active IK,ACh;
IK,AChc) have been identiﬁed in cAFmyocytes [11,12,23,33,34]. IK,AChc,
resulting from increased open frequency and open probability of
single IK,ACh channels in the absence of agonists [23,33,34], can
contribute to the increased basal current in cAF. Enhanced inward-
rectiﬁer currents are more effective in stabilizing and accelerating
AF-sustaining rotors than changes in other ionic currents [35] due
to their abilities to both shorten APD and hyperpolarize atrial
myocytes, thereby reducing voltage-dependent INa inactivation.
Although changes in mRNA and protein levels of the IK1 (Kir2.1)
and IK,ACh (Kir3.1 and Kir3.4) channel subunits have been reported
[11,12], the exact molecular basis of altered inward-rectiﬁer currentsremains incompletely understood. Alterations in various regulatory
mechanisms of IK1 and IK,ACh may contribute to AF-associated changes
in current and APD. For example, we have previously shown that
phosphorylation-dependent regulation of IK,ACh is altered in cAF
[29,33]. In the present study, we provided novel insights into the
Na+-dependent regulation of inward-rectiﬁer K+ currents.
We identiﬁed [Na+]i-dependent inhibition of the outward-current
component of the basal inward-rectiﬁer current in human atrial
myocytes and showed that this regulation resulted in a blunted APD
rate adaptation in both SR and cAF. The selective inhibition of the
outward-current component suggests modulation of rectiﬁcation of
basal inward-rectiﬁer current by [Na+]i. In line with our ﬁndings, it
has previously been shown that increased [Na+]i selectively reduces
IK1 single-channel amplitude of the outward-current component in
guinea-pig ventricular myocytes [30]. The exact mechanisms underly-
ing the inhibitory effect of [Na+]i are unknown but it has been sug-
gested that the Na+ interaction site is located near the Mg2+-binding
site. In particular, two negatively-charged residues (D172 and E224)
in the second transmembrane domain of the IK1 channel subunit
Kir2.1 appear to be critical determinants of inward rectiﬁcation [13].
Although not signiﬁcant, we also observed a strong trend towards
reduced basal inward-rectiﬁer current at 60 mmol/L [Na+]i at
−100 mV. Under these supraphysiological conditions, our recordings
may not exclusively reﬂect IK1. In particular, a [Na+]i-dependent K+
current activating at [Na+]i > 30 mmol/L has been reported in
Fig. 7. Schematic representation of [Na+]i-dependent regulation of APD via IK1 and IK,ACh in human atrial myocytes. Increased heart rate elevates [Na+]i which, in addition to
increasing INaK, results in a reduction in IK1 and a stimulation of IK,ACh (both direct via D223 in Kir3.4 and indirect due to enhancement of the dissociation of Gβγ). In cAF, the direct
[Na+]i-dependent stimulation of IK,ACh is impaired, likely due to a reduction of Kir3.4 subunits. The impaired [Na+]i-dependent stimulation of IK,ACh blunts APD rate dependence.
Novel insights for human atrial myocytes obtained in this study are indicated in blue.
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current in human atrial myocytes could mask a [Na+]i-dependent
reduction of the inward-component of IK1.
Whereas IK1 is active under basal conditions, inward rectiﬁer IK,ACh
channels are activated through stimulation of appropriate G-protein-
coupled receptors and subsequent binding of Gβγ-subunits. In the
atria, IK,ACh is activated by binding of the vagal neurotransmitter acetyl-
choline to muscarinic M2-receptors, thereby contributing to the regula-
tion of heart rate and APD. In the present study, we showed that [Na+]i-
dependent stimulation of IK,ACh shortens APD and found that reduced
agonist-dependent IK,ACh in cAF is also associated with impaired [Na+]i-
dependent regulation. It has previously been proposed that the down-
regulation of agonist-dependent IK,ACh could be a compensatory mecha-
nism to prevent excessive shortening of the effective refractory period
and suppress the initiation and maintenance of AF [11]. Our results sug-
gest that the loss of [Na+]i-dependent regulation of IK,ACh could have a
similar effect.
In atrial myocytes the IK,ACh channel is a heterotetrameric complex
composed of Kir3.1 and Kir3.4 subunits. The activation of IK,ACh channels
by [Na+]i is thought to involve the neutralization of a negatively
charged aspartate present in the C-terminus of Kir3.4 (but not Kir3.1),
allowing stronger binding of PIP2 [18]. Since Na+ interacts with Kir3.4
but not with Kir3.1, the subunit composition of the IK,ACh-channel
appears to be important for [Na+]i-dependent regulation of IK,ACh. We
hypothesized therefore that the reduced Kir3.4 expression in cAF [11]
could impair the [Na+]i-dependent regulation of IK,ACh. By quantifying
Kir3.1 and Kir3.4 expressions on the same blot-membrane, we identi-
ﬁed a 32% reduction in the relative Kir3.4:Kir3.1 expression in cAF.
Interestingly, this partial reduction appears sufﬁcient to completely
abolish the functional [Na+]i-dependent up-regulation of IK,ACh ob-
served in SR. This discrepancy could be due to the precise stoichiometry
in the membrane, e.g., a more pronounced reduction in Kir3.4membrane-expression, or could indicate the requirement of multiple
Kir3.4 subunits within a tetramer for [Na+]i-dependent regulation.
Such an ‘all-or-none’ regulation has previously been shown for
PKA-dependent stimulation of large-conductance Ca2+-activated K+
channels [37] and suggested for PKA-dependent stimulation of
slowly-activating delayed-rectiﬁer K+ channels [38]. However, we can-
not rule out that othermechanisms contribute to the [Na+]i-dependent
regulation of IK,ACh and that the altered subunit composition is an inde-
pendent phenomenon.
In addition to the regulation of the IK,ACh channels by direct binding
of Na+ to Kir3.4 subunits, it has also been described that [Na+]i can
accelerate the G-protein cycle [20]. Therefore, we cannot exclude that
an increased G-protein cycle contributes to the [Na+]i-dependent regu-
lation of CCh-activated IK,ACh observed in the present study. However,
since we used a highly saturating CCh concentration, putative effects
of [Na+]i that accelerate the signal via an effect on the G protein cycle
are likely to be blunted under these conditions.
4.2. Limitations
Due to limited tissue availability, we only studied myocytes
obtained from right-atrial appendages. As such, our ﬁndings may not
hold true for other atrial regions important for initiating AF. In particu-
lar, even if similar Na+-dependent regulation of inward-rectiﬁer K+
currents occurs in other regions, functional consequences for APD may
be different due to differences in parasympathetic innervation, altered
[Na+]i-handling, etc.
Myocytes from cAF patients had signiﬁcantly larger capacitances,
raising the possibility that the presentﬁndings are due to cellular hyper-
trophy. However, we did not ﬁnd a correlation between cell capacitance
and inward or outward-current components of basal or CCh-activated
current, suggesting that this inﬂuence, if any, is minor.
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of IK,ACh. As such, the basal inward-rectiﬁer current data may reﬂect a
combination of IK1 and IK,AChc, particularly in cAF [23,29,33]. Further
experiments investigating constitutive IK,ACh activity in single-channel
inside-out experiments are necessary to elucidate this aspect.
However, the fact that we did not observe signiﬁcant differences
in [Na+]i-dependent regulation of basal inward-rectiﬁer current
between SR and cAF (despite differences in [Na+]i-dependent IK,ACh
regulation) suggests that the contribution of IK,AChc was small
under our experimental conditions. Moreover, since the model for-
mulations were based on the total Ba2+-sensitive inward-rectiﬁer
K+ current, any effect of IK,AChc on APD was implicitly taken into ac-
count in the simulations.
[Na+]i-dependent regulation of APD is mediated by several
currents (Fig. 7). Previous work has highlighted an important role of
INaK. Here, we extended these observations by showing that
[Na+]i-dependent changes in inward-rectiﬁer K+ currents (inhibition
of IK1 in the face of a blunted stimulation of IK,ACh) apparently offset
the INaK-induced APD shortening at fast rates in cAF, blunting APD
rate dependence (Fig. 7). However, other [Na+]i-dependent process-
es may also contribute to APD rate dependence and inﬂuence AF sus-
ceptibility. Further work is needed to identify the exact role of each of
these processes in the dysregulation of APD rate adaptation and AF
pathophysiology. Our experimental results were obtained in the pres-
ence of non-physiological levels of extracellular [K+] (20 mmol/L) to
increase the reliability of experimental recordings. We explicitly in-
corporated the extracellular [K+] dependence into the computational
model (see supporting information) to obtain insights into the effects
of [Na+]i-dependent regulation of IK1 and IK,ACh on APD at physiolog-
ical extracellular [K+] levels. However, we cannot rule out that [Na+]i-
dependent regulation of these currents also depends on extracellular
[K+].
4.3. Novelty and potential signiﬁcance
The present study has provided novel insights into the [Na+]i-
dependent regulation of APD via inward-rectiﬁer K+ currents in
human atrial myocytes. To the best of our knowledge, this study is the
ﬁrst to show that in human atrial myocytes basal inward-rectiﬁer cur-
rent is inhibited by [Na+]i, whereas M-receptor-dependent activation
of IK,ACh increases with elevated [Na+]i and that cAF-dependent remod-
eling results in a loss of [Na+]i sensitivity which blunts APD rate adap-
tation. These results identify impaired [Na+]i-sensitivity of IK,ACh as
one potential mechanism contributing to the blunted APD rate depen-
dence in patients with cAF. Improved understanding of the molecular
and ionic consequences of cAF-related remodeling and their integration
into computationalmodels, as performed here for the [Na+]i-dependent
regulation of inward-rectiﬁer K+ currents, is expected to contribute to
the development of novel pharmacological approaches to treat AF
[39–41]. In this regard, our updates to the computational model of the
human atrial myocyte [10] facilitate future investigations into rate-
dependent properties of atrial electrophysiology in SR and cAF.
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